Eyenovia, Inc.

Home
United States
New York, NY
Eyenovia, Inc.

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Eyenovia, Inc., Pharmaceutical Company, 295 Madison Avenue, Suite 2400, New York, NY.

Eyenovia is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology.

11/12/2024

Indianapolis is now best known for the INDY500 and Eyenovia’s 2024 Ad Board!

Eyenovia had the privilege of engaging with a distinguished group of optometric leaders at our American Academy of Optometry advisory board meeting. Together, we explored the transformative potential of Clobetasol to revolutionize eye care, along with the exciting future of MydCombi. The insightful discussions provided valuable perspectives that will help us accelerate launch developments for the next-generation ophthalmic steroid and more innovative solutions.

We are deeply grateful for the time, expertise, and passion our advisors share. Your guidance is vital as we continue to push boundaries and advance the future of eye care. Thank you for joining us on this journey!

Interested in more information and how to get Clobetasol Propionate? clobetasolbid.com

Interested in more information and how to get MydCombi? mydcombi.com

Learn how Eyenovia is making it possible by visiting: https://bit.ly/3oEM9Ca

11/08/2024

Discover the future of pupil dilation at AAOpt 2024 with a Phase 4 study on MydCombi! Led by Josianne Manasse, OD and Denise Pensyl, OD from SUNY College of Optometry.

When: Friday, November 8, 2024
Where: AAOpt - Indianapolis
Location: Exhibit Hall H, Poster Board #109
Time: 1:00-3:00 PM

Learn more about MydCombi: https://bit.ly/mydcombi

Contraindications: Known hypersensitivity to any component of the formulation.
See Full Prescribing Information Here:
https://bit.ly/4btbPHk”

Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F

10/31/2024

Shelley Malkemus, a legend in ophthalmology, is happily heading to retirement! After years of dedication, attention to detail, and countless moments of support for the Eyenovia team and the industry, Shelley is officially closing this chapter of her remarkable career.

But don’t think she’s slowing down! Shelley is taking on a brand-new role as a full-time Grammy, stepping into her next adventure with open arms as her family grows and welcomes another precious grandchild.

Thank you, Shelley, for everything you’ve done to keep us on track and inspired. We wish you all the best in this exciting new phase—one that comes with more hugs, playdates, and plenty of love. 💙 Happy Retirement, Shelley!

10/30/2024

Blink, and it’s gone! It’s been just over a week since the American Academy of Ophthalmology, and Eyenovia extends its sincere thanks to the ophthalmic leaders who attended our AAO 2024 Advisory Board in Chicago. The thoughtful and engaging discussions surrounding our products were invaluable, providing key insights that will help propel the momentum behind our commercial launches of Clobetasol and MydCombi even further. We are excited to incorporate these perspectives as we continue to advance our portfolio. Thank you once again to our esteemed advisors for an evening of productive discussion and shared learning!

Interested in more information and how to get Clobetasol Propionate? clobetasolbid.com

Interested in more information and how to get MydCombi? mydcombi.com

Learn how Eyenovia is making it possible by visiting: https://bit.ly/3oEM9Ca

10/18/2024

Thank you, Francis Mah, MD, for being among the early adopters of Clobetasol, the next-generation ophthalmic steroid! We are pleased to see that you are actively prescribing Clobetasol for your patients. Renowned for his contributions as an ophthalmologist and respected researcher, speaker, and thought leader, Dr. Mah is dedicated to enhancing patient outcomes through innovative treatment approaches. Clobetasol empowers him to deliver powerful, swift relief from post-surgical pain and inflammation. With twice-a-day dosing, this state-of-the-art treatment has the potential to deliver quicker recovery times and improved overall patient experience.

Interested in more information and how to get Clobetasol Propionate? clobetasolbid.com/

Learn how Eyenovia is making it possible by visiting: https://bit.ly/3oEM9Ca

INDICATIONS AND USAGE: Clobetasol Propionate Ophthalmic Suspension 0.05% is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery.

CONTRAINDICATIONS: Clobetasol Propionate Ophthalmic Suspension 0.05% is contraindicated in most active viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures.

Full Prescribing Information: https://lnkd.in/gWYjgSiN

10/10/2024

Dagny Zhu, M.D. — — the Medical Director and Partner of NVISION Eye Centers Rowland Heights, was one of the first in the US to implement Clobetasol into her practice and post-operative patient care. She stated, “I’m excited for the ease of twice-a-day dosing for our patients. I also look forward to using Clobetasol to treat postop inflammation in our surgical patients with greater peace of mind as the data suggests a low risk of IOP spikes.”

As a key opinion leader in advanced cataract surgery and LASIK surgery, Dr. Zhu has been featured in over 200 lectures, presentations, publications, and press features. We are thrilled to have an expert like herself using Clobetasol!

Learn more about NVISION and Dr. Zhu: https://lnkd.in/gJ5rfZbQ

Interested in more information and how to get Clobetasol Propionate? clobetasolbid.com/

Learn how Eyenovia is making it possible by visiting: https://bit.ly/3oEM9Ca

INDICATIONS AND USAGE: Clobetasol Propionate Ophthalmic Suspension 0.05% is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery.

CONTRAINDICATIONS: Clobetasol Propionate Ophthalmic Suspension 0.05% is contraindicated in most active viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures.

Full Prescribing Information: https://lnkd.in/gWYjgSiN

09/11/2024

THIS IS A BIG DEAL – Clobetasol has arrived! The future of post-surgical pain and inflammation management has officially landed in the US. The official launch begins shortly!
Stay tuned for more updates.

Contraindications:
Clobetasol Propionate Ophthalmic Suspension 0.05% is contraindicated in most active viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures.

See Full Prescribing Information Here:

08/27/2024

Julie Whitcomb, PhD stole the Show at WIO!

Julie Whitcomb, PhD, captivated the audience this weekend at Women in Ophthalmology with her deep dive into the “Effects of APNT™ Nanolization on Ocular Distribution for Clobetasol Propionate.” Her presentation shed light on the unique benefits clobetasol offers in ophthalmology, sparking conversations about Eyenovia’s bright future.

Kudos to Julie and everyone at WIO for driving forward the future of eye care!

Couldn’t make it to the session? View the poster here. https://lnkd.in/gTQa5nPs

Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F

08/22/2024

Keep Your Eyes on Innovation at Women in Ophthalmology!

Join us in sunny Carlsbad, CA, this Saturday, August 24, as our very own Julie Whitcomb, PhD shares the “Effects of APNT™ Nanolization on Ocular Distribution for Clobetasol Propionate” between 11:05-11:50 AM. Don’t miss this insightful presentation on what makes clobetasol unique to ophthalmology.

Session: Poster Session I
Monitor: 4
Date: Saturday, August 24
Time: 11:05am - 11:50am

Good luck to all the brilliant minds at WIO this weekend—let’s make waves in ophthalmology.

SCHEDULE: https://lnkd.in/gmdw4b7i

Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F

08/15/2024

With over 25 years of experience, Dr. Wayne H. Martin, MD, drwaynehmartin.com leads a team of specialized doctors who offer a wide range of services, including optometry, LASIK, treatments for conditions like cataracts, macular degeneration, and glaucoma. Dr. Martin and his team understand the closely interconnected relationship between eye health and overall health, and they choose MydCombi for dilation.

Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F

hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

Contraindications: Known hypersensitivity to any component of the formulation.
See Full Prescribing Information Here:
https://bit.ly/4btbPHk

08/12/2024

When it comes to dry eye, we have our bases loaded. We are on the mound and ready to pitch some terrific updates in our game plan to address dry eye disease with a field of options:

A New Foundation for Treatment: A potentially faster-acting cyclosporine therapy with SGN Nanopharma Inc

Adding On to Existing Therapies: A new class of drug that is being developed for adjunctive treatment with Senju Pharmaceutical.

Alleviating Acute Flare-Ups: Co-developing Clobetasol Propionate Ophthalmic Suspension (0.05%) with Formosa Pharmaceuticals, Inc.

With these all-stars and cutting-edge solutions, Eyenovia is ready to hit it out of the park and take the lead against dry eye!

Learn how Eyenovia is making it possible by visiting https://bit.ly/3oEM9Ca

08/07/2024

For over three decades, Beverly Hills Institute of Ophthalmology https://lnkd.in/ganJ5wYz has been regarded as one of the most reputable and technologically advanced eye care providers in the Beverly Hills and South Bay regions. Through personal, concierge-style service, Dr. Billy Pan, MD, and his team deliver eye care that is fully customized for optimal patient satisfaction and excellent results. In line with their commitment to premium and customizable patient care, they choose MydCombi for dilation.

Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F

Contraindications: Known hypersensitivity to any component of the formulation.

See Full Prescribing Information Here:
https://bit.ly/4btbPHk

Address

295 Madison Avenue, Suite 2400
New York, NY
10017

Telephone

+19172891117

Website

http://www.eyenoviabio.com/

Alerts

Be the first to know and let us send you an email when Eyenovia, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Eyenovia, Inc.:

Shortcuts

Featured

Magnus Wellness
16 E 40th Street, Fl 4

Want your practice to be the top-listed Clinic in New York?